In AD, barrier compromise is primarily attributed to genetic mutations, particularly in the filaggrin (FLG) gene, leading to increased transepidermal water loss (TEWL) and heightened susceptibility to environmental allergens and microbial colonization, notably by Staphylococcus aureus (34–36). Here, FLG is linked to Alzheimer disease.